News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
52,691 Results
Type
Article (3484)
Company Profile (6)
Press Release (49197)
Section
Business (13716)
Career Advice (56)
Deals (1572)
Drug Delivery (15)
Drug Development (9369)
Employer Resources (10)
FDA (919)
Job Trends (1169)
News (23184)
Policy (1361)
Tag
2025 Best Places to Work (1)
2026 Best Places to Work (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Standard (1)
Academia (267)
Accelerated approval (14)
ADA (5)
Adcomms (6)
Allergies (15)
Alliances (4604)
ALS (144)
Alzheimer's disease (941)
Antibody-drug conjugate (ADC) (100)
Approvals (974)
Artificial intelligence (176)
ASCO (85)
Autoimmune disease (95)
Automation (13)
Bankruptcy (17)
Belgium (8)
Best Places to Work (1036)
BIO (6)
Biologics (21)
Biomarkers (1)
BIOSECURE Act (5)
Biosimilars (2)
BioSpace Insights (20)
Biotechnology (9)
Bispecific (8)
Bladder cancer (34)
Brain cancer (10)
Breast cancer (222)
Cancer (1621)
Cardiovascular disease (111)
Career advice (44)
Career pathing (6)
CAR-T (33)
CDC (1)
CDMO (28)
Cell-line development (1)
Cell therapy (126)
Cervical cancer (10)
Clinical research (9089)
Collaboration (452)
Commercialization (8)
Compensation (29)
Complete response letters (8)
COVID-19 (164)
CRISPR (15)
CRO (3)
C-suite (146)
Cystic fibrosis (26)
Data (2176)
Decentralized trials (1)
Denatured (1)
Depression (35)
Dermatology (22)
Diabetes (67)
Diagnostics (1790)
Digital health (14)
Diversity, equity & inclusion (1)
Drug discovery (72)
Drug pricing (5)
Drug shortages (1)
Duchenne muscular dystrophy (68)
Earnings (5104)
Editorial (4)
Employer branding (6)
Employer resources (11)
ESMO (105)
Events (8889)
Executive appointments (105)
Eye disease (2)
FDA (1429)
Fibrodysplasia Ossificans Progressiva (1)
Fragile X (3)
Friedreich's ataxia (10)
Frontotemporal dementia (29)
Funding (269)
Gene editing (27)
Generative AI (9)
Gene therapy (150)
GLP-1 (99)
Government (220)
Grass and pollen (1)
Guidances (29)
Healthcare (1387)
Hematology (32)
HIV (3)
Huntington's disease (24)
Idiopathic pulmonary fibrosis (4)
IgA nephropathy (22)
Immunology and inflammation (51)
Immuno-oncology (32)
Indications (44)
Infectious disease (185)
Inflammatory bowel disease (54)
Influenza (5)
Intellectual property (23)
Interviews (10)
IPO (731)
Job creations (162)
Job search strategy (37)
JPM (6)
Kidney cancer (4)
Kidney disease (28)
Labor market (18)
Layoffs (38)
Leadership (2)
Legal (95)
Licensing (13)
Liver cancer (23)
Longevity (12)
Lung cancer (254)
Lung diease (2)
Lymphoma (79)
Machine learning (12)
Management (2)
Manufacturing (199)
Marketing (2)
MASH (55)
Medical affairs (1)
Medical device (474)
Medtech (484)
Melanoma (22)
Mergers & acquisitions (942)
Metabolic disorders (189)
Middle East (1)
mRNA (35)
Multiple sclerosis (53)
Multispecific (1)
NASH (2)
Netherlands (8)
Neurodegenerative disease (266)
Neuropsychiatric disorders (23)
Neuroscience (1553)
Neurotech (1)
NextGen: Class of 2026 (286)
Non-profit (276)
Now hiring (25)
Obesity (61)
Opinion (31)
Ovarian cancer (82)
Pain (20)
Pancreatic cancer (92)
Parkinson's disease (195)
Partnered (3)
Patents (58)
Patient advocacy (1)
Patient recruitment (156)
Patient selection (19)
Peanut (4)
People (3569)
Peptides (6)
Pharmaceutical (1)
Phase 1 (3385)
Phase 2 (4769)
Phase 3 (2190)
Pipeline (2222)
Policy (24)
Postmarket research (87)
Preclinical (915)
Press Release (5)
Prostate cancer (86)
Psychedelics (9)
Radiopharmaceuticals (28)
Rare diseases (216)
Real estate (455)
Recruiting (6)
Regenerative medicine (3)
Regulatory (1764)
Reports (10)
Research institute (334)
Resumes & cover letters (9)
Rett syndrome (4)
RNA editing (4)
RSV (2)
Saudi Arabia (1)
Schizophrenia (31)
Series A (40)
Series B (22)
Sickle cell disease (16)
Special edition (4)
Spinal muscular atrophy (9)
Sponsored (6)
Startups (253)
Stem cells (2)
Stomach cancer (6)
Substance use disorders (3)
Supply chain (12)
Switzerland (6)
Tariffs (6)
The Weekly (6)
Vaccines (62)
Venture capital (17)
Weight loss (24)
Wet AMD (1)
Women's health (23)
Worklife (1)
Date
Last 7 days (97)
Last 30 days (466)
Last 365 days (3956)
2026 (3644)
2025 (3658)
2024 (4088)
2023 (4314)
2022 (4838)
2021 (4874)
2020 (3932)
2019 (3099)
2018 (2160)
2017 (2449)
2016 (2170)
2015 (2390)
2014 (1588)
2013 (1318)
2012 (1318)
2011 (1438)
2010 (1259)
Location
Africa (44)
Alabama (8)
Arizona (32)
Arkansas (1)
Asia (3415)
Australia (739)
California (2241)
Canada (340)
China (220)
Colorado (118)
Connecticut (68)
Delaware (52)
Europe (8766)
Florida (276)
Georgia (40)
Illinois (127)
India (9)
Indiana (58)
Iowa (7)
Japan (121)
Kansas (7)
Kentucky (8)
Louisiana (7)
Maine (6)
Maryland (262)
Massachusetts (1686)
Michigan (27)
Minnesota (40)
Missouri (46)
Montana (8)
Nebraska (4)
Nevada (51)
New Hampshire (4)
New Jersey (396)
New Mexico (15)
New York (517)
North Carolina (191)
North Dakota (1)
Northern California (1258)
Ohio (36)
Oklahoma (10)
Oregon (12)
Pennsylvania (344)
Puerto Rico (2)
Rhode Island (5)
South America (35)
South Carolina (3)
Southern California (814)
Tennessee (34)
Texas (320)
United States (7036)
Utah (115)
Virginia (59)
Washington D.C. (10)
Washington State (138)
Wisconsin (30)
52,691 Results for "elpis biomed".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Longeveron Announces Updated Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
October 26, 2026
·
12 min read
Press Releases
Orchestra BioMed Announces Proposed Public Offering
November 6, 2026
·
6 min read
Press Releases
Longeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
September 17, 2026
·
14 min read
Press Releases
Harbour BioMed’s Partner Spruce Biosciences Separates CRHX-101 Program into Adrenyx Biosciences, Advancing Development of Harbour BioMed-Originated Antibody through a Standalone Company
November 17, 2026
·
4 min read
Press Releases
Harbour BioMed Appoints Dr. Sanjay Keswani as Scientific Advisor in Neuroscience
November 17, 2026
·
4 min read
Press Releases
Orchestra BioMed Announces Virtue SAB Presentation at TCT 2026
October 29, 2026
·
8 min read
Press Releases
Harbour BioMed Appoints Ms. Vivian Feng as Head of External Collaboration
November 5, 2026
·
3 min read
Press Releases
Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference
November 17, 2026
·
2 min read
Press Releases
Orchestra BioMed Reports Third Quarter 2026 Financial Results and Highlights Recent Business Updates
November 10, 2026
·
15 min read
Press Releases
Anaconda Biomed Secures $56 Million Financing from New and Existing Investors
September 23, 2026
·
3 min read
1 of 5,270
Next